Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Endometrial Cancer
Interventions
DEVICE

Cytology

Two cervical samples are collected using a cervical brush or swab, following the standard procedure for cervical cytology. Cells are taken from the cervix using a brush/spatula during a gynecological exam. (1) The first sample is kept in the clinical center's pathology department for examination. (2) The second sample is sent to MiMARK's facilities for the investigational project, where it will be processed and stored for future cohort selection and analysis.

Trial Locations (2)

08908

RECRUITING

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

08035

RECRUITING

Hospital Universitari Campus Vall d'Hebron, Barcelona

Sponsors
All Listed Sponsors
collaborator

Hospital Vall d'Hebron

OTHER

lead

MiMARK Diagnostics, S.L.

INDUSTRY

NCT07148154 - Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations | Biotech Hunter | Biotech Hunter